Kailera Therapeutics, Inc. (KLRA) Insider Trading -- Recent Executive & Director Transactions

16 insiders reported 37 Form 4 transactions for Kailera Therapeutics, Inc. (KLRA) over the past 18 months (most recent 2026-06-11). Recent activity: Renaud Ronald C JR (CEO & President) Buy 38,094 shares, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (10% Owner) Buy 9.5M shares, WONG RODERICK (10% Owner) Buy 10.3M shares, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (10% Owner) Buy 2.0M shares, WONG RODERICK (10% Owner) Buy 500,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-11Renaud Ronald C JRCEO & PresidentBuy38,094$199,994
2026-04-22Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% OwnerBuy9.5M$0
2026-04-22WONG RODERICK10% OwnerBuy10.3M$0
2026-04-22Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% OwnerBuy2.0M$0
2026-04-22WONG RODERICK10% OwnerBuy500,000$8.0M
2026-04-22RTW INVESTMENTS, LP10% OwnerBuy500,000$8.0M
2026-04-22RTW INVESTMENTS, LP10% OwnerBuy10.3M$0
2026-04-20Bain Capital Fund XIV, L.P.10% OwnerBuy8.4M$134.4M
2026-04-20Bain Capital Life Sciences Investors, LLC10% OwnerBuy16.9M$0
2026-04-20BAIN CAPITAL INVESTORS LLC10% OwnerBuy17.9M$0
2026-04-20Kaplan Andrew T.DirectorBuy17.9M$0
2026-04-20BCPE Perseus Investor, LP10% OwnerBuy17.9M$0
2026-04-20Bain Capital Life Sciences IV General Partner, LLC10% OwnerBuy16.9M$0
2026-04-20Bain Capital XIV General Partner, LLC10% OwnerBuy17.9M$0
2026-04-20Bain Capital Life Sciences Fund IV, L.P.10% OwnerBuy16.9M$0
2026-04-20Bain Capital Fund XIV, L.P.10% OwnerBuy17.9M$0
2026-04-20Koppel AdamDirectorBuy16.9M$0
2026-04-20BCLS Fund IV Investments, L.P.10% OwnerBuy16.9M$0
2026-04-20BCLS Fund IV Investments GP, LLC10% OwnerBuy16.9M$0
2026-04-20Bain Capital Life Sciences Investors, LLC10% OwnerBuy4.1M$0
2026-04-20BCLS Fund IV Investments, L.P.10% OwnerBuy4.1M$0
2026-04-20BCLS Fund IV Investments GP, LLC10% OwnerBuy4.1M$0
2026-04-20Koppel AdamDirectorBuy4.1M$0
2026-04-20Bain Capital Life Sciences Fund IV, L.P.10% OwnerBuy4.1M$0
2026-04-20BCPE Perseus Investor GP, LLC10% OwnerBuy17.9M$0

Source: SEC Form 4 filings · as of 2026-06-11